Literature DB >> 29238177

The mediating role of psychological symptoms on falls risk among older adults with osteoarthritis.

Sumaiyah Mat1, Chin Teck Ng1,2,3, Farhana Fadzil4, Faizatul Izza Rozalli4, Maw Pin Tan1,5.   

Abstract

The purpose of this study was to investigate the role of fear of falling (FoF) and psychological symptoms in explaining the relationship between osteoarthritis (OA) symptom severity and falls. Individuals aged ≥65 years with ≥2 falls or ≥1 injurious fall over the past 12 months were included in the falls group, while volunteers aged ≥65 years with no history of falls over 12 months were recruited as controls. The presence of lower extremity OA was determined radiologically and clinically. Severity of symptoms was assessed using the Western Ontario and McMaster Universities Arthritis Index (WOMAC) questionnaire. FoF and psychological status were measured with the shortened version of the Falls Efficacy Scale-International and the 21-item Depression, Anxiety and Stress Scale (DASS-21), respectively. Of 389 (229 fallers, 160 non-fallers) potential participants, mean (SD) age: 73.74 (6.60) years, 141 had clinical OA and 171 had radiological OA. Fallers with both radiological OA and clinical OA had significantly higher FoF and DASS-21 scores than non-fallers. FoF was significantly positively correlated with symptom severity in fallers and non-fallers with radiological and clinical OA. Depression, anxiety, and stress scores were only significantly correlated with symptom severity among fallers but not non-fallers in both clinical and radiological OA. The relationship between mild symptoms and reduced risk of falls compared to no symptoms in those with radiological OA was attenuated by increased anxiety. The increased falls risk associated with severe symptoms compared to mild symptoms in clinical OA was attenuated by FoF. FoF may, therefore, be a potentially modifiable risk factor for OA-associated falls which could be considered in future intervention studies.

Entities:  

Keywords:  aged; falls; fear of falling; osteoarthritis; psychological status

Mesh:

Year:  2017        PMID: 29238177      PMCID: PMC5716391          DOI: 10.2147/CIA.S149991

Source DB:  PubMed          Journal:  Clin Interv Aging        ISSN: 1176-9092            Impact factor:   4.458


Introduction

Osteoarthritis (OA) is the most prevalent chronic degenerative joint disease world-wide.1 Aging is a major risk factor for OA with one in three individuals aged ≥75 years reported to have severe OA changes on their knee radiographs.2 Its prevalence, alongside that of many chronic medical conditions, is expected to rise with the rapidly aging global population. OA is associated with deficits in balance control.3 Among individuals with severe OA, 50% have reported at least one fall in the preceding year.2 However, one in three older adults aged ≥65 years also experience at least one fall annually regardless of OA status.4,5 Existing published evidence on the relationship between OA and falls have used a variety of different methods for the identification of their OA subjects, including presence of knee pain, self-reported physical diagnosed OA, clinical OA based on agreed criteria, and radiological evidence of OA. These studies also often reported the relationship between OA and balance measures or falls risk rather than actual fall events.6–9 Furthermore, a recent study revealed a biphasic relationship between OA and falls with older individuals with radiological evidence of OA with mild OA symptoms less likely to experience falls compared to those with radiological OA with no symptoms, while individuals with clinical OA and severe symptoms are more likely to experience falls than those with mild symptoms.10 Both falls and OA adversely affect the older individuals’ psychological well-being and quality of life (QoL).11,12 Strong negative associations were observed between depressive mood and fear of falling (FoF) with QoL in older fallers,13 while increased pain and functional limitations were found to decrease QoL in patients with OA.11 Psychological issues among fallers with OA have not been examined previously. We therefore conducted a case–control study comparing older fallers and non-fallers with knee OA, determined using both radiological and clinical criteria, to identify potential differences in FoF and psychological symptoms among fallers and non-fallers with OA.

Methods

Study population

This was a cross-sectional case–control study. Subjects aged ≥65 years with either a history of two falls or one injurious fall over the past 12 months were recruited from the Departments of Emergency Medicine, Primary Care, and Geriatric Medicine at a teaching hospital in greater Kuala Lumpur. Control participants with no falls (non-fallers) over the previous 12 months were recruited through media and word-of-mouth advertising. Participants were excluded if they had clinically diagnosed dementia (ICD-10 definition), severe physical disabilities, or major psychiatric illnesses. Demographic details were obtained from all participants. This study was approved by the University of Malaya Medical Centre Medical Ethics Committee (925.4) and complied with the Helsinki Declaration of 1975, revised in 1983. Written informed consent was obtained from all study participants.

Diagnosis of OA

All participants were assessed for the presence of knee OA using two different definitions of OA, radiological OA and clinical diagnosis of OA, based on predefined criteria. The influence of OA according to each definition on falls was evaluated separately.

Radiographic diagnosis of OA

Standardized knee radiographs were obtained in the standing antero-posterior view in all consenting participants. These images were assessed by a radiologist blinded of clinical data. The severity of OA was determined by the Kellgren–Lawrence (KL) grading scale,14 with a score of 0 indicating no knee OA and the maximal score of 4 indicating severe OA. Subjects with KL grades of 2–4 were considered subjects with radiological OA. Participants without radiological OA were excluded in subsequent analysis involving those with radiological OA only.

Clinical diagnosis of OA

Clinical diagnosis of OA was made by a rheumatologist, blinded from clinical data, based on the American College of Rheumatology criteria. Clinical diagnosis of knee OA required the presence of knee arthralgia, plus any 3 of the following: 1) age >50 years, 2) morning stiffness, 3) crepitus on active motion in at least one side, 4) bony enlargement in at least one side, and 5) no palpable warmth of synovia in both knees.15 Participants without clinical OA were excluded from analyses involving those with clinical OA only.

Pain, stiffness, and functional ability

Pain, stiffness, and functional ability were assessed by the Western Ontario and McMaster Universities Arthritis Index (WOMAC) questionnaire visual analog scale version, in English, Malay, Chinese, or Tamil. The scores for each item were obtained by measuring the distance along the line from the marker at the far left of each analog scale to the point at which the patient’s mark intersects the horizontal line on the analog scale. The score of each subscale as well as the grand total score was calculated. The maximum total length or score for pain, stiffness, and physical function subscales were 500 mm, 200 mm, and 1,700 mm, respectively.16 Individuals with no pain, no stiffness, and no impairment in functional ability were those with a score of zero for pain, stiffness, and physical function. The sum of the individual component scores for pain, stiffness, and physical function was calculated to obtain the total WOMAC score. Using 25th, 50th, and 75th percentile values as ordinal cutoffs, the non-normally distributed total WOMAC score was further categorized into 4 groups: no symptoms (0 mm), mild symptoms (1–200 mm), moderate symptoms (201–465 mm), and severe symptoms (≥466 mm).

Falls efficacy and psychological status

FoF

The shortened version of the Falls Efficacy Scale-International (short FES-I) was used. The short FES-I consists of seven items on a 4-point Likert scale, with 1 indicating no concern and 4 indicating severe concern. The minimum and maximum scores for the short FES-I are therefore 7 and 28, respectively.17 To allow for adjustment for potential confounders, cutoffs were developed using the median values; subjects with a score of ≥11 were considered to have greater FoF.

Depression, anxiety, and stress

Depression, anxiety, and stress were measured with the 21-item Depression, Anxiety, and Stress Scale (DASS-21). This is a self-reported measure in which subjects rate the frequency and severity of the negative emotions of depression, anxiety, and stress over the previous week. Frequency or severity ratings are made on a series of 4-point scales, with 0 indicating “did not apply to me at all” and 3 indicating “applied to me very much, or most of the time.”18 The scores were calculated individually for the three components: depression, anxiety, and stress. Because the DASS-21 is the short version of DASS (which has 42 items), the final score for each item were multiplied by 2.19 The total score for each components was dichotomized using median values as the cutoffs,20 depression ≥4, anxiety ≥4, and stress ≥8, respectively.

Statistical analysis

The SPSS 20.0 (IBM Corporation, Armonk, NY, USA) statistical package was used for statistical analysis. Normality was assessed using the Kolmogorov–Smirnov test. Mean values with SD or median with interquartile range were expressed for normally and non-normally distributed continuous data accordingly. The independent t-test and Mann–Whitney U test were employed for parametric and non-parametric data, respectively. Categorical variables were expressed as frequencies with percentages in parentheses and compared with the chi-squared test. Spearman’s rank correlation was used to evaluate the correlation between WOMAC subscales with FoF and DASS-21 domain scores. Using cutoffs described earlier, continuous data were grouped into dichotomous variables. Subsequently, logistic regression analysis using fall as a dependent variable was performed to determine potentially mediating effects of FoF and psychological status on the relationship between OA severity and falls. Dummy variables were created for comparisons between multiple categories, with the lowest category (no arthritis or mild arthritis) as the reference category. The exponential value of the parameter estimate, B, for each variable, which would represent the adjusted odds ratio (OR) as a measure of the strength of association was presented along with its 95% CI.

Results

Demographics

A total of 389 subjects, 229 fallers and 160 non-fallers, with a mean age of 72.2±6.1 years, were evaluated and screened for the presence of OA. One hundred and forty-one (36.2%) individuals had clinically diagnosed OA based on the ACR criteria. Knee X-rays were available for 205 participants, and 171 (83%) had radiological evidence of OA. Characteristics of fallers and non-fallers with radiological and clinical OA are summarized in Table 1. Fallers were significantly older than non-fallers in both the groups. There were ethnic differences between fallers and non-fallers with clinical OA. A greater proportion of fallers compared to non-fallers had severe OA symptoms in clinical OA. A higher percentage of non-fallers were seen with “mild” OA symptoms in radiological OA, compared to asymptomatic OA (Table 1).
Table 1

Characteristics of individuals with radiological OA and clinical OA according to fall status

Radiological OA (n=171)
Clinical OA (n=141)
Fallers(n=106)Non-fallers(n=65)p-valueFallers(n=81)Non-fallers(n=60)p-value
Age (years), mean (SD)75.28 (6.92)71.31 (4.65)<0.00175.93 (6.85)71.98 (5.54)<0.001
Female sex, n (%)75 (70.8)50 (76.9)0.37758 (71.6)47 (78.3)0.365
BMI (kg/m2), mean (SD)24.73 (4.22)24.42 (3.34)0.62325.05 (4.31)25.42 (3.83)0.601
Ethnicity*, n (%)
 Malay14 (13.2)12 (18.5)Reference11 (13.6)14 (23.3)Reference
 Chinese71 (67.0)46 (70.8)0.52152 (64.2)40 (66.7)0.268
 Indian17 (16.0)4 (6.2)0.05816 (19.8)3 (5.0)0.010
 Others4 (3.8)3 (4.6)0.8762 (2.5)3 (5.0)0.869
Comorbidities, n (%)
 Heart diseases9 (8.5)3 (4.6)0.3367 (8.6)4 (6.8)0.769
 Hypertension57 (53.8)34 (52.3)0.85252 (64.2)31 (52.5)0.166
 Diabetes mellitus32 (30.2)13 (20.0)0.14226 (32.1)13 (22.0)0.190
 Stroke7 (6.6)3 (4.6)0.5915 (6.2)2 (3.4)0.699
 Atrial fibrillation2 (1.9)1 (1.5)1.0002 (2.5)1 (1.7)1.000
 Visual impairment26 (24.5)11 (16.9)0.24118 (22.2)12 (20.3)0.789
WOMAC grand total score*, n (%)
 No symptoms27 (25.5)16 (24.6)Reference00NA
 Mild19 (17.9)28 (43.1)0.03618 (22.2)25 (41.7)Reference
 Moderate25 (23.6)13 (20.0)0.77921 (25.9)22 (36.7)0.516
 Severe35 (33.0)8 (12.3)0.05842 (51.9)13 (21.7)0.001

Notes:

Logistic regression with dummy variables. Categorized using percentile cutoffs from total WOMAC score. “No symptoms”: 0 mm. “Mild”: 1–200 mm. “Moderate”: 201–465 mm. “Severe”: ≥466 mm. Mean age and BMI were compared using Student’s independent t-test. The bold font indicates statistical significance.

Abbreviations: BMI, body mass index; OA, osteoarthritis; IQR, interquartile range; FES-I, Falls Efficacy Scale-International; DASS-21, 21-item Depression, Anxiety, and Stress Scale; WOMAC, Western Ontario and McMaster Universities questionnaire; NA, not applicable.

FoF and psychological status among fallers and non-fallers with different types of OA

In Table 2, fallers with either radiological or clinical OA had significantly greater FoF and reported significantly more severe depressive symptoms than non-fallers. Due to the non-normally distributed data, the individual domain scores were then dichotomized using median cutoffs to allow for adjustment for potential confounders using logistic regression analyses. After adjustment for the potential confounders of age, gender, ethnicity, and comorbidities, the association between greater FoF and falls remained significant in both the types of OA. However, the association between depression and falls in radiological OA group was no longer statistically significant after the same adjustment (Table 2).
Table 2

Association between falls and psychological scores for individuals with radiological OA and clinical OA

Radiological OA (n=171)
Clinical OA (n=141)
Fallers (n=106)Non-fallers (n=65)OR (95% CI)p-valueAdjusted ORa (95% CI)p-valueFallers (n=81)Non-fallers (n=60)OR (95% CI)p-valueAdjusted ORa (95% CI)p-value
Short FES-I,* median (IQR)14 (10–20)9 (7–13)<0.00115 (10–20)10 (7–15)<0.001
DASS-21,* median (IQR)
 Depression score12 (1–23)4 (0–12)0.00512 (4–28)4 (0–12)0.003
 Anxiety score4 (0–8)4 (0–8)0.2528 (0–16)4 (0–16)0.246
 Stress score8 (4–24)4 (0–24)0.09010 (4–28)8 (0–24)0.243
Short FES-I ≥11, n (%)70 (66.7)19 (31.1)4.42 (2.25 to 8.70)<0.0014.00 (1.88 to 8.50)<0.00156 (71.8)26 (45.6)3.04 (1.48 to 6.22)0.0023.06 (1.34 to 7.01)0.008
DASS-21, n (%)
 Depression ≥478 (75.0)33 (52.4)2.73 (1.40 to 5.30)0.0032.06 (0.99 to 4.29)0.05460 (76.9)32 (56.1)2.60 (1.24 to 5.47)0.0122.34 (1.03 to 5.30)0.043
 Anxiety ≥468 (66.0)34 (53.1)1.58 (0.83 to 3.02)0.1611.31 (0.65 to 2.63)0.44556 (72.7)34 (58.6)1.77 (0.85 to 3.68)0.1251.78 (0.80 to 3.99)0.160
 Stress ≥830 (47.6)68 (65.4)2.08 (1.10 to 3.93)0.0251.77 (0.87 to 3.41)0.12253 (67.9)32 (56.1)1.66 (0.82 to 3.36)0.1621.52 (0.69 to 3.37)0.300

Notes: The bold font indicates statistical significance.

Mann–Whitney U test was used for the non-parametric continuous data. Dichotomized data were categorized using median values.

Adjusted for age, gender, ethnicity, and comorbidities.

Abbreviations: OA, osteoarthritis; OR, odds ratio; IQR, interquartile range; FES-I, Falls Efficacy Scale-International; DASS-21, 21-item Depression, Anxiety, and Stress Scale.

FoF and psychological domains correlated with OA symptom severity in fallers and non-fallers

Table 3 documents the correlation coefficients (Spearman’s rho) between FoF, psychological status, and grand total of WOMAC score in fallers and non-fallers who had OA, diagnosed radiologically or clinically. Among fallers with radiological OA or clinical OA, symptom severity was significantly and positively correlated with FoF and all three psychological domains (p<0.01). In contrast, among the non-fallers, symptom severity was only significantly correlated with FoF regardless of the method of OA diagnosis. Symptom severity correlated with depression only in those with radiological OA (Table 3).
Table 3

Correlation between short FES-I and DASS-21 scores and total WOMAC scores among fallers and non-fallers, with radiological and clinical OA

Total WOMAC scoreRadiological OA
Clinical OA
FallersNon-fallersFallersNon-fallers
Short FES-I0.375**0.515**0.453**0.397**
DASS-21
 Depression0.439**0.258*0.469**0.177
 Anxiety0.287**0.0690.241**0.147
 Stress0.256**0.1490.358**0.222

Notes:

p<0.01;

p<0.05.

Abbreviations: WOMAC, Western Ontario and McMaster Universities questionnaire; FES-I, Falls Efficacy Scale-International; DASS-21, 21-item Depression, Anxiety, and Stress Scale; OA, osteoarthritis.

Multivariate logistic regression evaluating the relationship between OA severity and falls

Table 4 explores the mediating roles of FoF and psychological domains on the association between symptom severity and falls according to OA diagnosis. Models 1–5 assessed the relationship between symptom severity and falls in those with radiological OA, while models 6–10 explored the relationship between symptom severity and falls in those with clinical OA.
Table 4

The effects of fear of falling and psychological status in the relationship between symptom severity and falls

Falls OR (95% CI)
Model 1aModel 2bModel 3cModel 4dModel 5e
Radiological OA (n=171)
 No symptoms (ref)
 Mild0.386 (0.15 to 0.98)0.33 (0.12 to 0.87)0.38 (0.15 to 0.97)0.40 (0.16 to 1.01)0.39 (0.15 to 0.97)
 Moderate0.99 (0.36 to 2.70)0.59 (0.19 to 1.81)0.95 (0.35 to 2.62)1.02 (0.36 to 2.89)0.97 (0.35 to 2.66)
 Severe2.45 (0.84 to 7.16)1.14 (0.37 to 3.84)2.63 (0.85 to 8.13)2.95 (0.94 to 9.22)2.74 (0.90 to 8.39)

Model 6aModel 7bModel 8cModel 9dModel 10e

Clinical OA (n=141)
 No symptomsNANANANANA
 Mild (ref)
 Moderate1.29 (0.51 to 3.27)0.93 (0.34 to 2.52)1.35 (0.53 to 3.47)1.46 (0.56 to 3.79)1.36 (0.53 to 3.51)
 Severe3.92 (1.51 to 10.20)2.56 (0.90 to 7.28)3.71 (1.37 to 10.07)4.33 (1.56 to 12.00)4.06 (1.49 to 11.07)

Notes: Bold font indicates statistical significance. No symptoms =0 mm, mild symptoms =1–200 mm, moderate symptoms =201–465 mm, and severe symptoms ≥466 mm.

Adjusted for age, gender, ethnicity, and comorbidities.

Adjusted for age, gender, ethnicity, comorbidities, and fear of falling (short FES-I).

Adjusted for age, gender, ethnicity, comorbidities, and depression (DASS-21 score).

Adjusted for age, gender, ethnicity, comorbidities, and anxiety (DASS-21 score).

Adjusted for age, gender, ethnicity, comorbidities, and stress (DASS-21 score).

Abbreviations: NA, not applicable; OA, osteoarthritis; OR, odds ratio.

Symptom severity and falls in radiological OA

Comparisons were made with falls as the dependent variable and categorical severity of OA as independent variables using no OA symptoms as the reference group. In Model 1, following adjustments for the potential confounders of age, gender, ethnicity, and comorbidities, mild OA symptoms in radiological OA was associated with reduced risk of falls (OR =0.38, 95% CI =0.15 to -0.98) compared to those with radiological OA and no symptoms. No significant difference in falls risk was observed in those with moderate OA symptoms or severe OA symptoms compared to those with no symptoms in this model. In Model 2, the protective relationship between mild OA symptoms remained after adjustments were made for short FES-I scores (OR =0.33, 95% CI =0.12 to 0.87). This relationship also remained statistically significant after adjustment for DASS depression (Model 3: OR =0.38, 95% CI =0.15 to 0.97) and DASS stress scores (Model 4: OR =0.39, 95% CI =0.15 to 0.97). However, adjustment for DASS anxiety scores led to attenuation of the protective effect of mild OA symptoms against falls compared to no OA symptoms in those with radiological OA (Model 4: OR =0.40, 95% CI =0.16 to 1.01).

Symptom severity and falls in clinical OA

Comparisons were made using falls as the dependent variable and OA symptom severity category. As the presence of symptom is requisite for the diagnosis of clinical OA, OA symptom severity as determined by the WOMAC scores was categorized only according to the mild, moderate, and severe categories. Model 6 suggests that individuals with clinical OA and severe OA symptoms were significantly more likely to experience falls compared to those with mild OA symptoms (OR =3.92, 95% CI =1.51 to 10.20). This relationship was attenuated after adjustment for short FES-I scores (OR =2.56, 95% CI =0.90 to 7.28). However, DASS depression, anxiety, and stress scores did not influence the relationship between severe OA symptoms in those with clinical OA and falls (Models 8–10). Those with moderate OA symptoms did not display any difference in falls risk compared to those with mild OA symptoms in all models (Table 4).

Discussion

Among individuals with OA, fallers were significantly more likely to experience FoF and depression, regardless of whether the presence of OA was determined using radiological imaging or clinical assessment. When the relationship between severity of OA symptoms and psychological status were assessed independently among fallers and non-fallers, however, there was a significant correlation between severity of depression, anxiety, and stress with OA severity scores in fallers regardless of diagnostic criteria, but not non-fallers. Further multivariate analyses revealed that the increased risk of falls associated with severe clinical OA was mediated by FoF while the protective effect of mild symptoms in those with radiological OA was in fact mediated by symptoms of anxiety. Our findings, therefore, highlight a potential role of psychological status and FoF in determining the risk of falls in those older individuals with OA. Our study evaluated the psychological factors that influence falls risk in individuals with OA using two established methods of determining the presence of OA. Published studies have previously established the relationship between psychological status, including depression and FoF and increased risk of falls among general older populations.21 The relationship between falls and clinically significant depressive symptoms was also identified in subjects with self-reported OA in the Health and Retirement study.22 In a separate study involving those with clinical OA, a high level of anxiety was associated with poorer self-reported physical function but not gait and balance impairment quantified by physical performance measure of function.23 As highlighted earlier, these previous studies had used varying definitions of OA and may not necessarily employ actual fall events as their primary outcome. Our study has therefore emphasized that psychological factors do play a role in falls risk regardless of OA definitions. In addition, our study had compared actual fallers with non-fallers rather than employing surrogate measures such as balance performance, as in previous studies. The etiology of psychological symptoms in OA and the increased psychological burden in fallers with OA has not been well elucidated. Pain and joint stiffness associated with OA are chronic, though often branded less severe than other inflammatory joint conditions. The long-term effects of joint pain and stiffness could have a direct consequence on mood.24 In addition, a previous study has demonstrated a significant association between FoF and pain.25 The presence of OA, however, also influences joint stability, which occurs as a result of ligamentaous laxity from deconditioning occurring as a consequence of activity avoidance due to joint symptoms. Knee buckling, which occurs as a result of joint instability, is in turn, associated with FoF.26 Furthermore, joint pain and stiffness, instability, FoF, and reduced physical activity all lead to reduced functional ability, which will also adversely affect psychological well-being. The increased risk of FoF and depression among fallers with OA compared to non-fallers may imply that fallers were either more likely to experience the adverse psychological consequences of OA or that fallers with OA experience additional psychological burden over non-fallers with OA. However, when further within group analyses were employed, while the dose–response relationship is observed between FoF and OA symptom severity in both fallers and non-fallers with OA, the dose–response relationship between depression, stress, and anxiety and OA symptom severity only among fallers. The cross-sectional design of our study does not allow for the determination of the temporal relationships between FoF and depression with falls.24 We further explored the effects of FoF, depression, anxiety, and stress on the differential relationship of severity of OA symptoms with falls using multivariate logistic regression. The reduced risk of falls observed among those with radiological OA and mild symptoms had previously been reported.10 Our mediation analysis, however, suggests that symptoms of anxiety may account for the reduced falls risk in those with radiological OA and mild symptoms over those with radiological OA and no symptoms. This suggests that those with increased anxiety may exhibit increased vigilance or avoidance of challenging activities which then reduces their risk of falling.27,28 The exposure of these individuals to extrinsic risk factors for falls such as physical environment, assistive devices, or footwear may also be reduce.21 Conversely, while individuals with clinical OA and severe symptoms were significantly more likely to experience falls than those with mild symptoms, this relationship was not influenced by psychological status. Our findings were consistent with that of Quach and Burr who also found no interaction between clinically significant depressive symptoms with falls in their subjects with OA.22 FoF, on the other hand, seemed to account for the excess falls risk associated with severe OA compared to mild OA among individuals with clinical OA. Our cross-sectional findings, as before, does not allow us to determine any causal relationship between FoF and falls in individuals with clinical OA, but does, however, highlight FoF as a potentially modifiable risk factor for falls among those with severe clinical OA. A recent systematic review suggested that exercise interventions may reduce FoF in community-dwelling general older populations.29 Now, the use of actual psychological interventions in the management of FoF is also being evaluated.30 The determination of the value of exercise and psychological interventions on FoF and falls may therefore be worthwhile in individuals with clinical OA. As mentioned earlier, the cross-sectional design of our study precludes the establishment of temporality or causation. Fallers in our study also consisted of those with recurrent or injury falls, who will be considered high-risk fallers. The risk of injury and healthcare burden are particularly high among this group of fallers, which may limit the applicability of our findings to those who sustain one accidental fall with no injury, but may suffer adverse psychosocial consequence as a result. In addition, the presence of falls in the previous 12 months was determined through self-report, which may be subject to recall bias.31 A larger, more robust, prospective study to help establish the temporal relationship between FoF and other psychological symptoms and falls in individuals with OA should now be conducted to aid further understanding of the complex relationships between psychological status, OA, and falls.32,33

Conclusion

Older fallers with radiological and clinical OA have an increased FoF and depressive symptoms compared to non-fallers. A dose–response relationship exists between FoF, depression, anxiety, and stress with OA symptom severity among fallers with OA. Further exploratory analyses suggest mediating effects of anxiety on the protective effect of mild symptoms among those with radiological OA and FoF on the increased risk of falls among those with severe clinical OA. Our findings highlight the important role of psychological status in falls among older individuals with OA, which will help determine the direction of future studies on strategies to reduce the burden on falls in those with OA.
  29 in total

1.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

2.  Depressive symptoms, chronic pain, and falls in older community-dwelling adults: the MOBILIZE Boston Study.

Authors:  Laura H P Eggermont; Brenda W J H Penninx; Rich N Jones; Suzanne G Leveille
Journal:  J Am Geriatr Soc       Date:  2012-01-27       Impact factor: 5.562

3.  Using the Depression Anxiety Stress Scale 21 (DASS-21) across cultures.

Authors:  Tian P S Oei; Sukanlaya Sawang; Yong Wah Goh; Firdaus Mukhtar
Journal:  Int J Psychol       Date:  2013-02-21

4.  Characteristics associated with fear of falling and activity restriction in community-living older persons.

Authors:  Susan L Murphy; Christianna S Williams; Thomas M Gill
Journal:  J Am Geriatr Soc       Date:  2002-03       Impact factor: 5.562

5.  The development of fear of falling among community-living older women: predisposing factors and subsequent fall events.

Authors:  Susan L Murphy; Joel A Dubin; Thomas M Gill
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2003-10       Impact factor: 6.053

Review 6.  Exercise for reducing fear of falling in older people living in the community: Cochrane systematic review and meta-analysis.

Authors:  Arun Kumar; Kim Delbaere; G A R Zijlstra; Hannah Carpenter; Steve Iliffe; Tahir Masud; Dawn Skelton; Richard Morris; Denise Kendrick
Journal:  Age Ageing       Date:  2016-05       Impact factor: 10.668

Review 7.  Osteoarthritis: epidemiology.

Authors:  Nigel Arden; Michael C Nevitt
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-02       Impact factor: 4.098

8.  The Short FES-I: a shortened version of the falls efficacy scale-international to assess fear of falling.

Authors:  Gertrudis I J M Kempen; Lucy Yardley; Jolanda C M van Haastregt; G A Rixt Zijlstra; Nina Beyer; Klaus Hauer; Chris Todd
Journal:  Age Ageing       Date:  2007-11-20       Impact factor: 10.668

9.  Falls and EQ-5D rated quality of life in community-dwelling seniors with concurrent chronic diseases: a cross-sectional study.

Authors:  Ulrich Thiem; Renate Klaaßen-Mielke; Ulrike Trampisch; Anna Moschny; Ludger Pientka; Timo Hinrichs
Journal:  Health Qual Life Outcomes       Date:  2014-01-08       Impact factor: 3.186

10.  Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.

Authors:  Christopher J L Murray; Ryan M Barber; Kyle J Foreman; Ayse Abbasoglu Ozgoren; Foad Abd-Allah; Semaw F Abera; Victor Aboyans; Jerry P Abraham; Ibrahim Abubakar; Laith J Abu-Raddad; Niveen M Abu-Rmeileh; Tom Achoki; Ilana N Ackerman; Zanfina Ademi; Arsène K Adou; José C Adsuar; Ashkan Afshin; Emilie E Agardh; Sayed Saidul Alam; Deena Alasfoor; Mohammed I Albittar; Miguel A Alegretti; Zewdie A Alemu; Rafael Alfonso-Cristancho; Samia Alhabib; Raghib Ali; François Alla; Peter Allebeck; Mohammad A Almazroa; Ubai Alsharif; Elena Alvarez; Nelson Alvis-Guzman; Azmeraw T Amare; Emmanuel A Ameh; Heresh Amini; Walid Ammar; H Ross Anderson; Benjamin O Anderson; Carl Abelardo T Antonio; Palwasha Anwari; Johan Arnlöv; Valentina S Arsic Arsenijevic; Al Artaman; Rana J Asghar; Reza Assadi; Lydia S Atkins; Marco A Avila; Baffour Awuah; Victoria F Bachman; Alaa Badawi; Maria C Bahit; Kalpana Balakrishnan; Amitava Banerjee; Suzanne L Barker-Collo; Simon Barquera; Lars Barregard; Lope H Barrero; Arindam Basu; Sanjay Basu; Mohammed O Basulaiman; Justin Beardsley; Neeraj Bedi; Ettore Beghi; Tolesa Bekele; Michelle L Bell; Corina Benjet; Derrick A Bennett; Isabela M Bensenor; Habib Benzian; Eduardo Bernabé; Amelia Bertozzi-Villa; Tariku J Beyene; Neeraj Bhala; Ashish Bhalla; Zulfiqar A Bhutta; Kelly Bienhoff; Boris Bikbov; Stan Biryukov; Jed D Blore; Christopher D Blosser; Fiona M Blyth; Megan A Bohensky; Ian W Bolliger; Berrak Bora Başara; Natan M Bornstein; Dipan Bose; Soufiane Boufous; Rupert R A Bourne; Lindsay N Boyers; Michael Brainin; Carol E Brayne; Alexandra Brazinova; Nicholas J K Breitborde; Hermann Brenner; Adam D Briggs; Peter M Brooks; Jonathan C Brown; Traolach S Brugha; Rachelle Buchbinder; Geoffrey C Buckle; Christine M Budke; Anne Bulchis; Andrew G Bulloch; Ismael R Campos-Nonato; Hélène Carabin; Jonathan R Carapetis; Rosario Cárdenas; David O Carpenter; Valeria Caso; Carlos A Castañeda-Orjuela; Ruben E Castro; Ferrán Catalá-López; Fiorella Cavalleri; Alanur Çavlin; Vineet K Chadha; Jung-Chen Chang; Fiona J Charlson; Honglei Chen; Wanqing Chen; Peggy P Chiang; Odgerel Chimed-Ochir; Rajiv Chowdhury; Hanne Christensen; Costas A Christophi; Massimo Cirillo; Matthew M Coates; Luc E Coffeng; Megan S Coggeshall; Valentina Colistro; Samantha M Colquhoun; Graham S Cooke; Cyrus Cooper; Leslie T Cooper; Luis M Coppola; Monica Cortinovis; Michael H Criqui; John A Crump; Lucia Cuevas-Nasu; Hadi Danawi; Lalit Dandona; Rakhi Dandona; Emily Dansereau; Paul I Dargan; Gail Davey; Adrian Davis; Dragos V Davitoiu; Anand Dayama; Diego De Leo; Louisa Degenhardt; Borja Del Pozo-Cruz; Robert P Dellavalle; Kebede Deribe; Sarah Derrett; Don C Des Jarlais; Muluken Dessalegn; Samath D Dharmaratne; Mukesh K Dherani; Cesar Diaz-Torné; Daniel Dicker; Eric L Ding; Klara Dokova; E Ray Dorsey; Tim R Driscoll; Leilei Duan; Herbert C Duber; Beth E Ebel; Karen M Edmond; Yousef M Elshrek; Matthias Endres; Sergey P Ermakov; Holly E Erskine; Babak Eshrati; Alireza Esteghamati; Kara Estep; Emerito Jose A Faraon; Farshad Farzadfar; Derek F Fay; Valery L Feigin; David T Felson; Seyed-Mohammad Fereshtehnejad; Jefferson G Fernandes; Alize J Ferrari; Christina Fitzmaurice; Abraham D Flaxman; Thomas D Fleming; Nataliya Foigt; Mohammad H Forouzanfar; F Gerry R Fowkes; Urbano Fra Paleo; Richard C Franklin; Thomas Fürst; Belinda Gabbe; Lynne Gaffikin; Fortuné G Gankpé; Johanna M Geleijnse; Bradford D Gessner; Peter Gething; Katherine B Gibney; Maurice Giroud; Giorgia Giussani; Hector Gomez Dantes; Philimon Gona; Diego González-Medina; Richard A Gosselin; Carolyn C Gotay; Atsushi Goto; Hebe N Gouda; Nicholas Graetz; Harish C Gugnani; Rahul Gupta; Rajeev Gupta; Reyna A Gutiérrez; Juanita Haagsma; Nima Hafezi-Nejad; Holly Hagan; Yara A Halasa; Randah R Hamadeh; Hannah Hamavid; Mouhanad Hammami; Jamie Hancock; Graeme J Hankey; Gillian M Hansen; Yuantao Hao; Hilda L Harb; Josep Maria Haro; Rasmus Havmoeller; Simon I Hay; Roderick J Hay; Ileana B Heredia-Pi; Kyle R Heuton; Pouria Heydarpour; Hideki Higashi; Martha Hijar; Hans W Hoek; Howard J Hoffman; H Dean Hosgood; Mazeda Hossain; Peter J Hotez; Damian G Hoy; Mohamed Hsairi; Guoqing Hu; Cheng Huang; John J Huang; Abdullatif Husseini; Chantal Huynh; Marissa L Iannarone; Kim M Iburg; Kaire Innos; Manami Inoue; Farhad Islami; Kathryn H Jacobsen; Deborah L Jarvis; Simerjot K Jassal; Sun Ha Jee; Panniyammakal Jeemon; Paul N Jensen; Vivekanand Jha; Guohong Jiang; Ying Jiang; Jost B Jonas; Knud Juel; Haidong Kan; André Karch; Corine K Karema; Chante Karimkhani; Ganesan Karthikeyan; Nicholas J Kassebaum; Anil Kaul; Norito Kawakami; Konstantin Kazanjan; Andrew H Kemp; Andre P Kengne; Andre Keren; Yousef S Khader; Shams Eldin A Khalifa; Ejaz A Khan; Gulfaraz Khan; Young-Ho Khang; Christian Kieling; Daniel Kim; Sungroul Kim; Yunjin Kim; Yohannes Kinfu; Jonas M Kinge; Miia Kivipelto; Luke D Knibbs; Ann Kristin Knudsen; Yoshihiro Kokubo; Soewarta Kosen; Sanjay Krishnaswami; Barthelemy Kuate Defo; Burcu Kucuk Bicer; Ernst J Kuipers; Chanda Kulkarni; Veena S Kulkarni; G Anil Kumar; Hmwe H Kyu; Taavi Lai; Ratilal Lalloo; Tea Lallukka; Hilton Lam; Qing Lan; Van C Lansingh; Anders Larsson; Alicia E B Lawrynowicz; Janet L Leasher; James Leigh; Ricky Leung; Carly E Levitz; Bin Li; Yichong Li; Yongmei Li; Stephen S Lim; Maggie Lind; Steven E Lipshultz; Shiwei Liu; Yang Liu; Belinda K Lloyd; Katherine T Lofgren; Giancarlo Logroscino; Katharine J Looker; Joannie Lortet-Tieulent; Paulo A Lotufo; Rafael Lozano; Robyn M Lucas; Raimundas Lunevicius; Ronan A Lyons; Stefan Ma; Michael F Macintyre; Mark T Mackay; Marek Majdan; Reza Malekzadeh; Wagner Marcenes; David J Margolis; Christopher Margono; Melvin B Marzan; Joseph R Masci; Mohammad T Mashal; Richard Matzopoulos; Bongani M Mayosi; Tasara T Mazorodze; Neil W Mcgill; John J Mcgrath; Martin Mckee; Abigail Mclain; Peter A Meaney; Catalina Medina; Man Mohan Mehndiratta; Wubegzier Mekonnen; Yohannes A Melaku; Michele Meltzer; Ziad A Memish; George A Mensah; Atte Meretoja; Francis A Mhimbira; Renata Micha; Ted R Miller; Edward J Mills; Philip B Mitchell; Charles N Mock; Norlinah Mohamed Ibrahim; Karzan A Mohammad; Ali H Mokdad; Glen L D Mola; Lorenzo Monasta; Julio C Montañez Hernandez; Marcella Montico; Thomas J Montine; Meghan D Mooney; Ami R Moore; Maziar Moradi-Lakeh; Andrew E Moran; Rintaro Mori; Joanna Moschandreas; Wilkister N Moturi; Madeline L Moyer; Dariush Mozaffarian; William T Msemburi; Ulrich O Mueller; Mitsuru Mukaigawara; Erin C Mullany; Michele E Murdoch; Joseph Murray; Kinnari S Murthy; Mohsen Naghavi; Aliya Naheed; Kovin S Naidoo; Luigi Naldi; Devina Nand; Vinay Nangia; K M Venkat Narayan; Chakib Nejjari; Sudan P Neupane; Charles R Newton; Marie Ng; Frida N Ngalesoni; Grant Nguyen; Muhammad I Nisar; Sandra Nolte; Ole F Norheim; Rosana E Norman; Bo Norrving; Luke Nyakarahuka; In-Hwan Oh; Takayoshi Ohkubo; Summer L Ohno; Bolajoko O Olusanya; John Nelson Opio; Katrina Ortblad; Alberto Ortiz; Amanda W Pain; Jeyaraj D Pandian; Carlo Irwin A Panelo; Christina Papachristou; Eun-Kee Park; Jae-Hyun Park; Scott B Patten; George C Patton; Vinod K Paul; Boris I Pavlin; Neil Pearce; David M Pereira; Rogelio Perez-Padilla; Fernando Perez-Ruiz; Norberto Perico; Aslam Pervaiz; Konrad Pesudovs; Carrie B Peterson; Max Petzold; Michael R Phillips; Bryan K Phillips; David E Phillips; Frédéric B Piel; Dietrich Plass; Dan Poenaru; Suzanne Polinder; Daniel Pope; Svetlana Popova; Richie G Poulton; Farshad Pourmalek; Dorairaj Prabhakaran; Noela M Prasad; Rachel L Pullan; Dima M Qato; D Alex Quistberg; Anwar Rafay; Kazem Rahimi; Sajjad U Rahman; Murugesan Raju; Saleem M Rana; Homie Razavi; K Srinath Reddy; Amany Refaat; Giuseppe Remuzzi; Serge Resnikoff; Antonio L Ribeiro; Lee Richardson; Jan Hendrik Richardus; D Allen Roberts; David Rojas-Rueda; Luca Ronfani; Gregory A Roth; Dietrich Rothenbacher; David H Rothstein; Jane T Rowley; Nobhojit Roy; George M Ruhago; Mohammad Y Saeedi; Sukanta Saha; Mohammad Ali Sahraian; Uchechukwu K A Sampson; Juan R Sanabria; Logan Sandar; Itamar S Santos; Maheswar Satpathy; Monika Sawhney; Peter Scarborough; Ione J Schneider; Ben Schöttker; Austin E Schumacher; David C Schwebel; James G Scott; Soraya Seedat; Sadaf G Sepanlou; Peter T Serina; Edson E Servan-Mori; Katya A Shackelford; Amira Shaheen; Saeid Shahraz; Teresa Shamah Levy; Siyi Shangguan; Jun She; Sara Sheikhbahaei; Peilin Shi; Kenji Shibuya; Yukito Shinohara; Rahman Shiri; Kawkab Shishani; Ivy Shiue; Mark G Shrime; Inga D Sigfusdottir; Donald H Silberberg; Edgar P Simard; Shireen Sindi; Abhishek Singh; Jasvinder A Singh; Lavanya Singh; Vegard Skirbekk; Erica Leigh Slepak; Karen Sliwa; Samir Soneji; Kjetil Søreide; Sergey Soshnikov; Luciano A Sposato; Chandrashekhar T Sreeramareddy; Jeffrey D Stanaway; Vasiliki Stathopoulou; Dan J Stein; Murray B Stein; Caitlyn Steiner; Timothy J Steiner; Antony Stevens; Andrea Stewart; Lars J Stovner; Konstantinos Stroumpoulis; Bruno F Sunguya; Soumya Swaminathan; Mamta Swaroop; Bryan L Sykes; Karen M Tabb; Ken Takahashi; Nikhil Tandon; David Tanne; Marcel Tanner; Mohammad Tavakkoli; Hugh R Taylor; Braden J Te Ao; Fabrizio Tediosi; Awoke M Temesgen; Tara Templin; Margreet Ten Have; Eric Y Tenkorang; Abdullah S Terkawi; Blake Thomson; Andrew L Thorne-Lyman; Amanda G Thrift; George D Thurston; Taavi Tillmann; Marcello Tonelli; Fotis Topouzis; Hideaki Toyoshima; Jefferson Traebert; Bach X Tran; Matias Trillini; Thomas Truelsen; Miltiadis Tsilimbaris; Emin M Tuzcu; Uche S Uchendu; Kingsley N Ukwaja; Eduardo A Undurraga; Selen B Uzun; Wim H Van Brakel; Steven Van De Vijver; Coen H van Gool; Jim Van Os; Tommi J Vasankari; N Venketasubramanian; Francesco S Violante; Vasiliy V Vlassov; Stein Emil Vollset; Gregory R Wagner; Joseph Wagner; Stephen G Waller; Xia Wan; Haidong Wang; Jianli Wang; Linhong Wang; Tati S Warouw; Scott Weichenthal; Elisabete Weiderpass; Robert G Weintraub; Wang Wenzhi; Andrea Werdecker; Ronny Westerman; Harvey A Whiteford; James D Wilkinson; Thomas N Williams; Charles D Wolfe; Timothy M Wolock; Anthony D Woolf; Sarah Wulf; Brittany Wurtz; Gelin Xu; Lijing L Yan; Yuichiro Yano; Pengpeng Ye; Gökalp K Yentür; Paul Yip; Naohiro Yonemoto; Seok-Jun Yoon; Mustafa Z Younis; Chuanhua Yu; Maysaa E Zaki; Yong Zhao; Yingfeng Zheng; David Zonies; Xiaonong Zou; Joshua A Salomon; Alan D Lopez; Theo Vos
Journal:  Lancet       Date:  2015-08-28       Impact factor: 79.321

View more
  2 in total

1.  Analysis of the Associations between Arthritis and Fall Histories in Korean Adults.

Authors:  Jung Woo Lee; Seong Hun Kang; Hyo Geun Choi
Journal:  Int J Environ Res Public Health       Date:  2021-04-03       Impact factor: 3.390

2.  Falls and Recurrent Falls among Adults in A Multi-ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study.

Authors:  Wei Dai; Yih-Chung Tham; Miao-Li Chee; Nicholas Y Q Tan; Kah-Hie Wong; Shivani Majithia; Charumathi Sabanayagam; Ecosse Lamoureux; Tien-Yin Wong; Ching-Yu Cheng
Journal:  Sci Rep       Date:  2018-05-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.